TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo
Cell Reports · 2024-11 · 43 (11) · 114921
DOI: 10.1016/j.celrep.2024.114921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-11. Verfasst von Kexin Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Inflammation Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, SARS-CoV-2, COVID-19, Membrane Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Bailey Family Foundation, QIMR Berghofer Medical Research Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection and Inflammation Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia.
- Infection and Inflammation Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia; Australian Infectious Disease Research Centre, GVN Center of Excellence, Brisbane, QLD, Australia.
- Infection and Inflammation Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia. Electronic address: daniel.rawle@qimrberghofer.edu.au.
Förderung
- National Health and Medical Research Council
- Bailey Family Foundation
- QIMR Berghofer Medical Research Institute
- Department of Education, Australian Government
- Monash University
Zitieren
APA
Yan, K., Dumenil, T., Stewart, R., Bishop, C. R., Tang, B., Nguyen, W., Suhrbier, A., & Rawle, D. J. (2024). TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo. Cell Reports, 43(11), 114921. https://doi.org/10.1016/j.celrep.2024.114921
Vancouver
Yan K, Dumenil T, Stewart R, Bishop CR, Tang B, Nguyen W, et al. TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo. Cell Reports. 2024;43(11):114921. doi:10.1016/j.celrep.2024.114921
BibTeX
@article{Yan2024,
author = {Yan, Kexin and Dumenil, Troy and Stewart, Romal and Bishop, Cameron R and Tang, Bing and Nguyen, Wilson and Suhrbier, Andreas and Rawle, Daniel J},
title = {TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {11},
pages = {114921},
doi = {10.1016/j.celrep.2024.114921}
}
EUVIMED